|1.||Pichichero, Michael E: 2 articles (03/2007 - 03/2007)|
|2.||Ivanova, M: 1 article (08/2009)|
|3.||Marina, M: 1 article (08/2009)|
|4.||Kantardjiev, T: 1 article (08/2009)|
|5.||Kato, Sayaka: 1 article (06/2008)|
|6.||Tamai, Ikumi: 1 article (06/2008)|
|7.||Sai, Yoshimichi: 1 article (06/2008)|
|8.||Takahara, Seiko: 1 article (06/2008)|
|9.||Yabuuchi, Hikaru: 1 article (06/2008)|
|10.||Kato, Yukio: 1 article (06/2008)|
01/01/1980 - "These data suggest that cefamandole is effective in treatment of most anaerobic infections."
03/01/1979 - "These data suggest that cefamandole is effective in treatment of most anaerobic infections."
01/01/1983 - "These data suggest that cefamandole is an effective agent for the initial treatment of nonmeningitic infections in children."
07/01/1981 - "Pharmacology, Safety, and efficacy of cefamandole in childhood infections."
01/01/1980 - "The safety and efficacy of treatment with cefamandole were evaluated in 77 patients (from 33 institutions) with serious bone and joint infections. "
08/01/1984 - "Overall, cefamandole showed superior coverage in vitro against the biliary flora, but both drugs were equally effective in maintaining a low incidence of postoperative sepsis as well as a minimal number of febrile or total hospital days. "
04/01/1984 - "Preincisional cefamandole is effective in reducing postoperative sepsis after operations upon the gastrointestinal tract."
04/01/1984 - "A randomized prospective trial comparing the value of intravenous and preincisional cefamandole in reducing postoperative sepsis after operations upon the gastrointestinal tract."
09/01/1981 - "Bacteroides fragilis septicemia during cefamandole therapy."
06/01/1978 - "Therefore, in those patients with biliary tract sepsis, in whom a cephalosporin is indicated for therapy, cefamandole appears to be the drug of choice."
|3.||Wounds and Injuries (Trauma)
10/01/1994 - "Infective wound complications were observed only in the cefamandole group. "
10/01/1989 - "In the cefamandole group, colonization rates in anterior nares and chest skin or wound were 53.3% and 60% respectively before surgery and became 53.3% and 40% respectively after surgery. "
09/01/1987 - "The most common organism isolated from infected wounds with cefamandole was Staphylococcus aureus followed by S. "
11/01/1986 - "A postoperative dose of cefamandole 2 g iv q6h will provide sustained and therapeutic concentrations in the wound drainage of morbidly obese patients."
11/01/1986 - "Cefamandole distribution in serum, adipose tissue, and wound drainage in morbidly obese patients."
01/01/1980 - "Sputum levels were 0.27 to 2.5 microgram/ml. Cefamandole appears to be an effective antibiotic for treatment of gram-negative pneumonia caused by susceptible organisms."
07/01/1985 - "Although cefamandole has been recommended in empiric therapy for patients with community-acquired pneumonia and as a prophylactic agent for patients having various surgical procedures, other regimens are less expensive and just as effective. "
01/01/1980 - "cefamandole 1 000 mg 8 h and 500 mg 8 h, were compared in the treatment of assumed community-acquired pneumonia in 59 hospitalized adult patients. "
01/01/1980 - "Clinical experience with cefamandole in pneumonia."
03/01/1980 - "In 33.3% of patients treated, cefamandole was evaluated as quite useful in the treatment of pneumonia or lung abscess. "
|5.||Urinary Tract Infections (Urinary Tract Infection)
05/03/1980 - "Drug trials: treatment of urinary tract infection with multiple-dose intramuscular administration of cephamandole."
02/01/1977 - "Our studies indicate that a dosage regimen of 1 g of cefamandole every 8 h in patients with normal renal function results in urine concentrations sufficiently high for treatment of most common urinary tract infections. "
10/01/1984 - "In the intravenous cefamandole group there was only one patient who developed a urinary tract infection after operation. "
05/17/1980 - "Treatment of urinary tract infection with a single-dose intramuscular administration of cephamandole."
11/01/1979 - "The cefamandole half-life (1 1/2) on dialysis was 4.0 +/- 0.29 hr; off dialysis it was 13.9 +/- 4.2 hr. High urine concentrations of cefamandole in these patients suggests usefulness in urinary tract infection."
|2.||Anti-Bacterial Agents (Antibiotics)
|7.||Cefoperazone (Cefoperazone Sodium)
|10.||Cefoxitin (Cefoxitin Sodium)
|2.||Hip Replacement Arthroplasty (Total Hip Replacement)
|3.||Continuous Ambulatory Peritoneal Dialysis (CAPD)
|5.||Prostheses and Implants (Prosthesis)